LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids

P. Victoria, S. Monkley (susan.monkley1@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , G. , S. , M. Tammia (markus.tammia@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , G. , S. , K. Öst (karolina.ost@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , G. , S. , C. Overed-Sayer (catherine.overed-sayer@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , C. , U. Kingdom,Cambridge), P. Hazon (petra.hazon@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , G. , S. , D. E Wagner (darcy.wagner@med.lu.se / Department of Experimental Medical Sciences, L. Bioengineering and Regeneration, L. University, L. , S. Wallenberg Center for Molecular Medicine, L. University, L. , S. Lund Stem Cell Center, L. University, L. , S. , L. A Murray (lynne.murray1@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , C. , U. Kingdom,Cambridge)

Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Session: In vitro modelling of lung disease: reach out to the next dimension
Session type: E-poster
Number: 2051

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Victoria, S. Monkley (susan.monkley1@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , G. , S. , M. Tammia (markus.tammia@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , G. , S. , K. Öst (karolina.ost@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , G. , S. , C. Overed-Sayer (catherine.overed-sayer@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , C. , U. Kingdom,Cambridge), P. Hazon (petra.hazon@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , G. , S. , D. E Wagner (darcy.wagner@med.lu.se / Department of Experimental Medical Sciences, L. Bioengineering and Regeneration, L. University, L. , S. Wallenberg Center for Molecular Medicine, L. University, L. , S. Lund Stem Cell Center, L. University, L. , S. , L. A Murray (lynne.murray1@astrazeneca.com / Research and Early Development, R. & Immunology, B. R&D, A. , C. , U. Kingdom,Cambridge). LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids. 2051

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021

LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021


Engineering distal pulmonary epithelium from induced pluripotent stem cell (iPSC)-derived alveolar cells
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019

LSC - 2018 - Generation of alveolar epithelial cells from human induced pluripotent stem cells for a model of alveolar wound repair
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018


Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020

Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Using induced pluripotent stem cells to model the human lung alveolar epithelium
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018

Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021

Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis
Source: Eur Respir Monogr 2021; 91: 290-305
Year: 2021


Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021


The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012

Use of alveolar epithelial cells derived from induced pluripotent stem cell to study alveolar wound repair in vitro
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018

How can gene-editing of human pluripotent stem cells help cystic fibrosis?
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012